http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11185517-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ce2fdd1f33743aa488c0e36ecda0f38
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2019-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e69e1aab88ffb1ab9245cde4457040b4
publicationDate 2021-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-11185517-B2
titleOfInvention Pharmaceutical composition for treatment or remission of chronic myelogenous leukemia
abstract The present application provides a pharmaceutical composition for use in treatment or remission of patients with chronic myelogenous leukemia, wherein the composition comprises, as active ingredients, (2S)-2-[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoylamino]-4-methylpentanoic acid or a pharmacologically acceptable salt thereof, and 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide or a pharmacologically acceptable salt thereof, both of which are used at low doses.
priorityDate 2016-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018256668-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226704132
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233722018
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230926256
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399237
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12945730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413937
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6916047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439299
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73896894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226431830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399201
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45157500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395931

Total number of triples: 46.